Decades of discovery. A model that works. And the science that comes next.
Arthritis and autoimmune disease research doesn’t announce itself. It builds — through questions asked in early-career labs, through grants awarded before the world knows a scientist’s name, through discoveries that take decades to reach the treatments patients rely on today.
The ANRF 2026 Impact Report documents that build.
Inside, you’ll find fifty years of funded breakthroughs — from the foundational insight that gave rise to anti-TNF biologics, to CRISPR-based research now pointing toward a future where we don’t just treat disease flares, but disrupt the cellular memory that causes them. You’ll meet the scientists driving today’s most promising work in psoriatic arthritis and rheumatoid arthritis. And you’ll see the numbers behind ANRF’s Scholar Society program — a model designed not just to fund research, but to sustain the careers that produce it.
What’s inside the 2026 report:
- A decade-by-decade timeline of ANRF-funded discoveries that reshaped the field
- Scholar Society outcomes: what structured early-career support actually produces
- Profiles of current scholars asking the questions that will define the next generation of treatment
- The case for why this moment — with federal funding under pressure and the research pipeline at risk — demands continued investment
The science on the horizon will not be done by institutions alone. It will be done by individuals who need someone to believe in them before the results are in.
Click here to view our 2026 Impact Report:
